Companies & Industry »Company News»Company News Details
Company News Details

BSE   19 Sep 14 | 03:16 PM

1284.60 -12.15 (-0.94%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   19 Sep 14 | 03:05 PM

1285.25 -11.9 (-0.92%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,271.15 (1.06%)
1 Month : Rs 1,192.00 (7.77%)
1 Year : Rs 677.10 (89.72%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
TCS2,707.352.68
Cipla629.501.49
Maruti Suzuki3,091.001.49
Dr Reddy`s Labs3,226.151.20
H D F C1,065.151.07

Online Portfolio

You can create Online Portfolio here using the below button.